In the EAU model that targets the neuroretina, which is an experimental equivalent of the human autoimmune uveitis, immunization of fully VAD mice with the uveitogenic antigen (IRBP peptide) did not result in disease induction (Fig. 3). This evidence concerns the gene RBP3 and autoimmune uveitis.